International Medical Industries

Executive Summary

International Medical Industries (IMI) is a U.S.-based medical device company founded in 1969 that specializes in tamper-evident drug delivery and security products for compounding pharmacies and healthcare systems. Its portfolio includes caps, connectors, and needles designed to prevent drug diversion and enhance medication safety. IMI's products are FDA-registered and ISO 13485 certified, and the company emphasizes domestic manufacturing with a 'Made in the USA' label. IMI operates in the niche but critical market of drug diversion prevention, which is gaining regulatory attention due to the opioid crisis and compounding pharmacy safety concerns. As a private company, IMI has limited public financial data but benefits from recurring demand for its consumable products. Growth opportunities include expanding its product line, entering new healthcare segments (e.g., hospitals), and forming strategic partnerships with large pharmacy chains. The company's focus on tamper-evident technology positions it well amid increasing safety regulations.

Upcoming Catalysts (preview)

• Q3 2026FDA approval of new tamper-evident cap60% success
• Q4 2026Expansion into hospital systems50% success
• Q3 2026Partnership with major pharmacy chain40% success